期刊文献+

骨骼肌源性抑瘤物对恶性肿瘤抑制作用的研究 被引量:1

Suppressive Effect of Skeletal Muscle-derived Tumor Inhibitor on Maligant Tumors
暂未订购
导出
摘要 目的研究骨骼肌微环境因素对恶性肿瘤细胞增殖的影响,评价其在骨骼肌转移瘤罕见性中的意义。方法原代培养新生Wistar大鼠骨骼肌细胞,用MTT法分析、比较其条件性上清液(MMCM)对恶性肿瘤细胞(小鼠骨髓瘤细胞株SP2/0、鼻咽癌细胞株CNE、肺巨细胞癌细胞株PLA801C、人食管鳞癌细胞株Eca109、宫颈癌细胞株Hela)及正常非肿瘤细胞(金黄地鼠肾细胞株BHK-21)的体外抑瘤作用。结果MMCM分别与SP2/0、CNE、PLA801C、Eca109、Hela及BHK-21细胞共同培养后,对5株恶性肿瘤细胞的增殖均有明显抑制作用,而正常非肿瘤细胞株则未受影响。结论新生大鼠骨骼肌细胞可产生选择性抑制恶性肿瘤细胞增殖的抑瘤物质,这种抑瘤物质可能是临床上骨骼肌内罕见转移瘤现象的生物学基础。 Objective To explore the organic microenvironmental effect of skeletal muscles on the proliferation of malignant ceils and evaluate its significance in the rarity of metastases in skeletal muscles. Methods Prepare the primary culture of new born Wistar rat skeletal muscle ceils and collect the culture supernatant as murine skeletal muscle conditioned medium(MMCM). Analyze the suppressive effect in vitro of MMCM on the proliferation of malignant tumor ceils including murine myeloma ceil strain SP2/0, nasopharyngeal carcinoma ceil strain CNE, pulmonary cytomegalic carcinoma ceil strain PLA-801C , human oesophageal squamous ceil carci- noma strain Eca109 and cervical carcinoma ceil strain Hela. Results MMCM showed significant suppressive effect on the proliferations of all the five tumor cell strains. However, it showed no significant effect on normal cells. Conclusion The tumor inhibitors derived from new born Wistar rat skeletal muscle ceils selectively suppressed the proliferation of malignant tumors and provided a biological basis for the study on rare metastases in skeletal muscles.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第3期262-264,共3页 Chinese Journal of Biologicals
基金 全军"十.五"医药卫生科研基金资助项目(01MB073).
关键词 骨骼肌 抑瘤物 抑制作用 Skeletal muscle Tumor inhibitor Suppressive effect
  • 相关文献

参考文献9

  • 1Taylor DD,Gercel TC.Tumor-reactive immunoglobulins in ovarian cancer:diagnostic and therapeutic significance.Oncol Rep,1998,5(6):1519-1524.
  • 2郑梦利,罗成华.骨骼肌源性抑瘤物及其应用前景(文献综述)[J].国外医学(外科学分册),2003,30(1):45-46. 被引量:4
  • 3罗成华,蒋彦永,李向红,孟宪均,檀华.骨骼肌转移瘤的罕见性及骨骼肌微血管内皮细胞粘附分子意义的研究[J].军医进修学院学报,2000,21(1):8-10. 被引量:10
  • 4罗成华,蒋彦永,李向红,刘永学.骨骼肌转移瘤罕见性机制的实验研究[J].解放军医学杂志,2001,26(2):96-98. 被引量:6
  • 5Carmichael J,DeGraff WG,Gazdar AF,et al.Evaluation of a tetrazolium-based semiautomated colorimetric assay:assessment of chemosensitivity testing.Cancer Res,1987,47 (4):936-942.
  • 6Nicolson GL.Organ specificity of metastasis:role of preferential adhesion,invasion growth of malignant cells at specific secondary sites.Cancer Metastasis Rev,1988,7 (2):143-188.
  • 7Djaldetti M,Sredni B,Zigelman R,et al.Muscle cells produce a low molecular weight factor with anti-cancer activity.Clin Exp Metastasis,1996,14 (3):189-196.
  • 8Fishman P,Bar-Yehuda S,Vagman L.Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth.Cancer Res,1998,58(14):3181-3187.
  • 9Bar-Yehuda S,Farbstein T,Barer F,et al.Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.Clin Exp Metastasis,1999,17 (6):531-535.

二级参考文献23

  • 1高进,癌的侵袭与转移.基础研究与临床,1996年,90卷,182页
  • 2Menard O, et al. Ann Med Interne (Paris)1991; 142(6): 423-428.
  • 3Taylor DD, et al. Oncol Rep 1998; 5(6): 1519-1924.
  • 4Glockner JF,et al. Skeletal Radiol 2000; 29(5): 270-274.
  • 5Willis RA. In: Willis RA(eds). The spread of tumors in the human body (3 rd ed) p281-282. Butterworths, London 1973.
  • 6Damron TA, et al. Ann Surg Oncol 2000; 7(7): 526-534.
  • 7Damron TA,et al. Orthop Clin North Am 2000; 31(4): 661-673.
  • 8Oba K, et al. J Nippon Med Sci 2001; 68(3): 271-274.
  • 9Peh WC, et al. Skeletal Radiol 1999; 28(5): 298-304.
  • 10Yiotakis J, et al. J Laryngol Otol 2001; 115(1): 65-67.

共引文献15

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部